Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Clinical trial NCT00271063 · UNKNOWN
Trial details
- NCT number
- NCT00271063
- Sponsor
- Callisto Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.